KR890002101A - N-heterocyclyl-4-piperidinamine derivatives - Google Patents

N-heterocyclyl-4-piperidinamine derivatives Download PDF

Info

Publication number
KR890002101A
KR890002101A KR1019870006963A KR870006963A KR890002101A KR 890002101 A KR890002101 A KR 890002101A KR 1019870006963 A KR1019870006963 A KR 1019870006963A KR 870006963 A KR870006963 A KR 870006963A KR 890002101 A KR890002101 A KR 890002101A
Authority
KR
South Korea
Prior art keywords
alkyl
substituted
amino
hydrogen
alkyloxycarbonyl
Prior art date
Application number
KR1019870006963A
Other languages
Korean (ko)
Other versions
KR950010186B1 (en
Inventor
에드워드 쟈안센스 프란스
프란시스 헨스 죠제프
메오 기스라누스 토오레만스 죠제프
레오 기스라누스 토오테만스 죠제프
쟌 피이터 헤이칸트스 죠제프
쟌 피이터 헤이칸므스 죠제프
Original Assignee
쟈안센 파아마슈우티카 엔. 부이.
폴 아드리안 쟌 야안센
쟈안센 파아마슈우티카 엔.부이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 쟈안센 파아마슈우티카 엔. 부이., 폴 아드리안 쟌 야안센, 쟈안센 파아마슈우티카 엔.부이. filed Critical 쟈안센 파아마슈우티카 엔. 부이.
Priority to KR1019870006963A priority Critical patent/KR950010186B1/en
Publication of KR890002101A publication Critical patent/KR890002101A/en
Application granted granted Critical
Publication of KR950010186B1 publication Critical patent/KR950010186B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

내용 없음No content

Description

N-헤테로사이클릴-4-피페라딘아민 유도체N-heterocyclyl-4-piperadinamine derivatives

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.

Claims (1)

일반식(I)의 화합물, 그 산부가염, 또는 그 입체화학 이성체 1이상을 유효성분으로 항알레르기 작용의 효과량 함유하며, 1이상의 약제학적 담체로 이루어진 항 알레르기성 조성물.An anti-allergic composition comprising an effective amount of an antiallergic effect as an active ingredient of at least one compound of the general formula (I), an acid addition salt thereof, or a stereochemical isomer thereof, and comprising at least one pharmaceutical carrier. A 위의 일반식에서 L는 수소, C1-6알킬옥시카르보닐 또는 페닐메톡시카르보닐이고, A1=A2-A3=A4은 -CH=CH-CH=CH-(a), -N=CH-CH=CH-(b), -CH=N-CH=CH-(c), -CH=CH-N=CH-(d) 또는 -CH=CH-CH=N-(e)의 2가기인데 위(a) 내지 (e) 기중의 하나 또는 두개의 수소는 각각 따로 할로, C1-6알킬, C1-6알킬옥시, 트리플루오로메틸 또는 하이드록시로 치환될 수 있고, R은 수소 또는 C1-6알킬이며, R1은 수소, C1-10알킬, C3-6사이클로알킬, Ar1또는 하나 또는 두개의 Ar1기로 치환된 C1-6알킬이고, R2는 수소, C1-6알킬, C3-6사이클로알킬, (C1-6알킬)-CO-, (C1-6알콕시)-CO 또는 Ar2-C1-6알킬인데, 위에서 Ar1은 비치환 또는 치환된 페놀[치환체는 할로, 하이드록시, 니트로, 시아노, 트리플루오로메틸, C1-6알킬, C1-6알킬옥시, C1-6알킬티오, 메르캅토, 아미노, 모노 또는 디(C1-6알킬)아미노,카르복실 C1-6알킬옥시카르보닐 및 C1-6알킬 -CO-로 이루어진 그룹에서 각기 선택된 3개 이하의 치환기임] : 티에닐 ; 할로티에닐 ; 푸라닐 치환된 C1-6알킬 ; 피리디닐 ; 피라지닐 ; 티아졸릴 ; 또는C1-6알킬로 임의 치환된 이미다졸릴이고, Ar2는 비치환 또는 치환된 페놀[치환체는 할로, 하이드록시, 니트로, 시아노, 트리플루오로메틸, C1-6알킬, C11-6알콕시, C1-6알킬티오, 메르캅토, 아미노, 모노 또는 디(C1-6알킬)아미노, 카르복실 C1-6알킬옥시카르보닐, 및 (C1-6알킬)-CO로 이루어진 그룹에서 각기 선택된 3개 이하의 치환기임]이다.L in the formula above A is hydrogen, C 1-6 alkyloxycarbonyl or phenylmethoxycarbonyl, A 1 = A 2 -A 3 = A 4 is -CH = CH-CH = CH- (a), -N = CH-CH = CH- (b), -CH = N-CH = CH- (c), -CH = CH-N = CH- (d) or -CH = CH-CH = N- (e Is a divalent group, and one or two hydrogens of the above groups (a) to (e) may each be substituted with halo, C 1-6 alkyl, C 1-6 alkyloxy, trifluoromethyl or hydroxy , R is hydrogen or C 1-6 alkyl, R 1 is hydrogen, C 1-10 alkyl, C 3-6 cycloalkyl, Ar 1 or C 1-6 alkyl substituted with one or two Ar 1 groups, R 2 is hydrogen, C 1-6 alkyl, C 3-6 cycloalkyl, (C 1-6 alkyl) -CO-, (C 1-6 alkoxy) -CO or Ar 2 -C 1-6 alkyl, wherein Ar 1 is unsubstituted or substituted phenol [substituents are halo, hydroxy, nitro, cyano, trifluoromethyl, C 1-6 alkyl, C 1-6 alkyloxy, C 1-6 alkylthio, mercapto, amino , mono- or di (C 1-6 alkyl) amino, a car Acid C 1-6 alkyloxycarbonyl and substituent; each of the up to three selected from the group consisting of C 1-6 alkyl, -CO-: thienyl; Halothienyl; Furanyl substituted C 1-6 alkyl; Pyridinyl; Pyrazinyl; Thiazolyl; Or imidazolyl optionally substituted with C 1-6 alkyl, Ar 2 is unsubstituted or substituted phenol [substituents are halo, hydroxy, nitro, cyano, trifluoromethyl, C 1-6 alkyl, C 1 1 -6 with alkoxy, C 1-6 alkylthio, mercapto, amino, mono or di (C 1-6 alkyl) amino, carboxyl C 1-6 alkyloxycarbonyl, and (C 1-6 alkyl) -CO No more than three substituents each selected from the group consisting of: ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019870006963A 1987-07-01 1987-07-01 N-heterocyclryl-4-piperidinamine derivatives KR950010186B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019870006963A KR950010186B1 (en) 1987-07-01 1987-07-01 N-heterocyclryl-4-piperidinamine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019870006963A KR950010186B1 (en) 1987-07-01 1987-07-01 N-heterocyclryl-4-piperidinamine derivatives

Publications (2)

Publication Number Publication Date
KR890002101A true KR890002101A (en) 1989-04-07
KR950010186B1 KR950010186B1 (en) 1995-09-11

Family

ID=19262631

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019870006963A KR950010186B1 (en) 1987-07-01 1987-07-01 N-heterocyclryl-4-piperidinamine derivatives

Country Status (1)

Country Link
KR (1) KR950010186B1 (en)

Also Published As

Publication number Publication date
KR950010186B1 (en) 1995-09-11

Similar Documents

Publication Publication Date Title
KR900018098A (en) Pyridone Carboxylic Acids and Antibacterials
KR970706021A (en) A medicinal compounding agent consisting of N-substituted-o-toluidine derivatives, and a percutaneously absorbable broth agent (hereinafter, referred to as " medicinal preparations ", " medicinal preparations for oral administration "
YU23599A (en) Stabilized antihistamine syrup
KR930703303A (en) 1,4-benzothiazepine derivative
EP1340755A4 (en) Anti-helicobacterial agents
KR950016727A (en) How to increase thrombomodulin expression
KR927003525A (en) Sulfonanilide Derivatives and Medicines
KR970061246A (en) Pharmaceutical Compositions for Increasing Testosterone
TW354762B (en) Agent for prophylaxis or treatment of cataract
KR950702530A (en) Prostaglandin derivatives
IE821721L (en) Imidazole derivatives
KR890002101A (en) N-heterocyclyl-4-piperidinamine derivatives
EP1149832A4 (en) Benzamide derivatives and drugs containing the same
GB1340889A (en) Pesticidal phosphorus-containing barbiturates
WO1990012577A3 (en) Topical anti-angiogenic as hair growth inhibitors
KR910000702A (en) Quinolone Carboxylic Acid Derivatives
KR890012973A (en) Imidazole derivatives
KR980002033A (en) Triazole derivatives or salts thereof
KR940018351A (en) Nonatetraenoic Acid Derivatives
EP0936218A4 (en) Novel benzimidazole derivatives
FI80878B (en) FOERFARANDE FOER FRAMSTAELLNING AV FARMAKOLOGISKT ANVAENDBARA -ARYL- -PYRIDYLALKANSYRADERIVAT.
KR950703341A (en) Antiarrhythmics
GB2251539B (en) Fodder compositions
CA2148078A1 (en) Platelet aggregation inhibitor
KR930001910A (en) Hypotensive formulation

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20090910

Year of fee payment: 15

EXPY Expiration of term